Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign and date a consent form agreeing to take part in the study
- People who are willing to follow all study procedures and are available for the full duration of the study
- People who are male or female, aged 18 years or older
- People who a surgeon has determined are a good candidate for surgery
- People who have been diagnosed through laboratory testing with one of the following bladder cancer types: muscle-invasive bladder cancer, high-risk non-muscle-invasive bladder cancer, non-muscle-invasive bladder cancer that has not responded to BCG treatment, muscle-invasive bladder cancer where cisplatin is not suitable and surgery is planned upfront, or bladder cancer with mixed cell types (confirm with trial site)
- People whose organ function (such as kidneys, liver, and blood counts) meets the levels required by the study
- People with a general health and activity level rated at 2 or below on a standard medical scale (meaning they are able to carry out some daily activities independently) (confirm with trial site)
- People who have been medically cleared to do a heart and lung fitness test
- People who are willing to use personal or study-provided devices to track and carry out exercise routines
- People who are fluent in English or Spanish (for completing a quality-of-life questionnaire)
- People who have no known medical reasons to avoid high-intensity exercise
Who may not be able to join:
- People who have medical reasons that prevent them from doing aerobic exercise
- People who are currently taking part in a regular aerobic exercise program
- People who have recently developed chest pain or shortness of breath during physical activity
- People whose bladder cancer has been identified through laboratory testing as a specific type called micropapillary or sarcomatoid bladder cancer
- People whose cancer has spread to distant parts of the body (metastatic cancer)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 4349240871
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patient-reported days devoted to solitary psychological support; Number of patient-reported days devoted to exercise
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.